Skip to main content
. Author manuscript; available in PMC: 2018 Nov 8.
Published in final edited form as: AIDS. 2017 Jan 28;31(3):375–384. doi: 10.1097/QAD.0000000000001333

Fig. 2. Use of ART, HIV RNA and CD4+ cell count status in 341 HIV patients with drug-susceptible tuberculosis during 12 months after initiation of anti-TB therapy.

Fig. 2.

Eastern Europe (Belarus, Estonia, Georgia, Latvia, Lithuania, Poland, Romania, Ukraine, Russia); Western Europe (Belgium, Denmark, France, Italy, Spain, Switzerland, United Kingdom); Latin America (Argentina, Chile, and Mexico).